FibroGen v. Akebia: Arnold LJ addresses insufficiency, equivalence, second medical use claims, and much more By Léon Dijkman on Saturday, April 25, 2020 #IPKat Biogen insufficiency claim limitation common general knowledge equivalents indirect infringement insufficiency Léon Dijkman Second medical use uncertainty undue burden +